AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Receptors, TNF-Related Apoptosis-Inducing LigandHLA-DR3 AntigenHLA-DR AntigensHLA-DR4 AntigenHistory, 20th CenturyHLA-DR Serological SubtypesHistory, 21st CenturyHLA-DR2 AntigenTNF-Related Apoptosis-Inducing LigandHLA-DQ AntigensReceptors, Tumor Necrosis Factor, Member 25HLA-DR1 AntigenDiabetic RetinopathyHistory, 19th CenturyUnited StatesHLA-DR7 AntigenTime FactorsHLA-D AntigensHLA-B8 AntigenReceptors, Tumor Necrosis FactorHLA AntigensRisk FactorsMolecular Sequence DataIncidenceAge FactorsNeoplasmsHistocompatibility Antigens Class IIHLA-DR5 AntigenApoptosisForecastingTumor Necrosis Factor Ligand Superfamily Member 15Genes, MHC Class IIHLA-DRB1 ChainsAdhesins, Escherichia coliModels, BiologicalPrevalenceSignal TransductionRetrospective StudiesAllelesTreatment OutcomeHLA-DP AntigensAgingApoptosis Regulatory ProteinsDeinococcusInfant, NewbornDiabetes Mellitus, Type 1Amino Acid SequenceClinical Trials as TopicHistocompatibility TestingHistory, 18th CenturyFamous PersonsAge DistributionBase SequenceTumor Necrosis Factor Decoy ReceptorsAntigens, CD55Sex FactorsMutationPhenotypeHLA-A1 AntigenResearchHaplotypesGenotypeAwards and PrizesGenetic Predisposition to DiseaseCaspase 8Biomedical ResearchCaloric RestrictionEcosystemPregnancyRaphe NucleiPhylogenyDisease Models, AnimalCohort StudiesRisk AssessmentPortraits as TopicAntineoplastic AgentsHLA-DQ beta-ChainsT-LymphocytesCell Line, TumorWorld HealthFollow-Up StudiesProtein BindingSex DistributionPrognosisReceptors, Death DomainEuropeCanadaIndiaDrug DiscoveryPolymorphism, GeneticHLA-DR6 AntigenMembrane GlycoproteinsGeographyChinaHLA-B AntigensPublic HealthDisease SusceptibilityLongevityHLA-DRB4 ChainsAntibodies, Monoclonal